Cargando…

Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition

BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CS...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Yumi, Matsubara, Shyuichirou, Ding, Qiang, Tsukasa, Koichiro, Yoshimitsu, Makoto, Kosai, Ken-ichiro, Takao, Sonshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924257/
https://www.ncbi.nlm.nih.gov/pubmed/27349387
http://dx.doi.org/10.1186/s12943-016-0534-2
_version_ 1782439836058124288
author Miyazaki, Yumi
Matsubara, Shyuichirou
Ding, Qiang
Tsukasa, Koichiro
Yoshimitsu, Makoto
Kosai, Ken-ichiro
Takao, Sonshin
author_facet Miyazaki, Yumi
Matsubara, Shyuichirou
Ding, Qiang
Tsukasa, Koichiro
Yoshimitsu, Makoto
Kosai, Ken-ichiro
Takao, Sonshin
author_sort Miyazaki, Yumi
collection PubMed
description BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CSC-like properties of pancreatic cancer cells, in order to discover the key molecules controlling their unique properties. METHODS: Human pancreatic cancer cell lines, Capan-1, PANC-1, MIA PaCa-2 and Capan-1 M9 were used for our experiments in DMEM/F12 medium containing 10 % fetal bovine serum. Sphere formation assay, immunofluorescence staining, flow cytometric analysis and MTT cell viability assay were performed to investigate molecular signals and the efficacy in the treatment of pancreatic cancer cells. RESULTS: Inhibition of the Hh pathway significantly reduced the expression of stem cell marker CD133 and sphere formation, an index of self-renewal capacity, demonstrating the suppression of CSC-like properties. Moreover, the GLI inhibitor GANT61 induced greater reduction in sphere formation and cell viability of pancreatic cancer cells than the smoothened (SMO) inhibitor cyclopamine. This suggests that GLI transcription factors, but not SMO membrane protein, are the key molecules in the Hh pathway. The treatment using GANT61 in combination with the inhibition of mTOR, which is another key molecule in pancreatic CSCs, resulted in the efficient reduction of cell viability and sphere formation of an inhibitor-resistant cell line, showing the strong efficacy and wide range applicability to pancreatic CSC-like cells. CONCLUSIONS: Thus, this novel combination treatment could be useful for the control of pancreatic cancer by targeting pancreatic CSCs. This is the first report of the efficient elimination of pancreatic cancer stem-like cells by the double blockage of Hh/GLI and mTOR signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0534-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4924257
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49242572016-06-29 Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition Miyazaki, Yumi Matsubara, Shyuichirou Ding, Qiang Tsukasa, Koichiro Yoshimitsu, Makoto Kosai, Ken-ichiro Takao, Sonshin Mol Cancer Research BACKGROUND: Pancreatic cancer is one of the most lethal malignancies. The innovative treatments are required and now the cancer stem cells (CSCs) are expected to be an effective target for novel therapies. Therefore we investigated the significance of hedgehog (Hh) signaling in the maintenance of CSC-like properties of pancreatic cancer cells, in order to discover the key molecules controlling their unique properties. METHODS: Human pancreatic cancer cell lines, Capan-1, PANC-1, MIA PaCa-2 and Capan-1 M9 were used for our experiments in DMEM/F12 medium containing 10 % fetal bovine serum. Sphere formation assay, immunofluorescence staining, flow cytometric analysis and MTT cell viability assay were performed to investigate molecular signals and the efficacy in the treatment of pancreatic cancer cells. RESULTS: Inhibition of the Hh pathway significantly reduced the expression of stem cell marker CD133 and sphere formation, an index of self-renewal capacity, demonstrating the suppression of CSC-like properties. Moreover, the GLI inhibitor GANT61 induced greater reduction in sphere formation and cell viability of pancreatic cancer cells than the smoothened (SMO) inhibitor cyclopamine. This suggests that GLI transcription factors, but not SMO membrane protein, are the key molecules in the Hh pathway. The treatment using GANT61 in combination with the inhibition of mTOR, which is another key molecule in pancreatic CSCs, resulted in the efficient reduction of cell viability and sphere formation of an inhibitor-resistant cell line, showing the strong efficacy and wide range applicability to pancreatic CSC-like cells. CONCLUSIONS: Thus, this novel combination treatment could be useful for the control of pancreatic cancer by targeting pancreatic CSCs. This is the first report of the efficient elimination of pancreatic cancer stem-like cells by the double blockage of Hh/GLI and mTOR signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0534-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-27 /pmc/articles/PMC4924257/ /pubmed/27349387 http://dx.doi.org/10.1186/s12943-016-0534-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Miyazaki, Yumi
Matsubara, Shyuichirou
Ding, Qiang
Tsukasa, Koichiro
Yoshimitsu, Makoto
Kosai, Ken-ichiro
Takao, Sonshin
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title_full Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title_fullStr Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title_full_unstemmed Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title_short Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
title_sort efficient elimination of pancreatic cancer stem cells by hedgehog/gli inhibitor gant61 in combination with mtor inhibition
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924257/
https://www.ncbi.nlm.nih.gov/pubmed/27349387
http://dx.doi.org/10.1186/s12943-016-0534-2
work_keys_str_mv AT miyazakiyumi efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT matsubarashyuichirou efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT dingqiang efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT tsukasakoichiro efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT yoshimitsumakoto efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT kosaikenichiro efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition
AT takaosonshin efficienteliminationofpancreaticcancerstemcellsbyhedgehoggliinhibitorgant61incombinationwithmtorinhibition